Correlation Between Cassava Sciences and Axsome Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cassava Sciences and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cassava Sciences and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cassava Sciences and Axsome Therapeutics, you can compare the effects of market volatilities on Cassava Sciences and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cassava Sciences with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cassava Sciences and Axsome Therapeutics.
Diversification Opportunities for Cassava Sciences and Axsome Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cassava and Axsome is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Cassava Sciences and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and Cassava Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cassava Sciences are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of Cassava Sciences i.e., Cassava Sciences and Axsome Therapeutics go up and down completely randomly.
Pair Corralation between Cassava Sciences and Axsome Therapeutics
Given the investment horizon of 90 days Cassava Sciences is expected to under-perform the Axsome Therapeutics. In addition to that, Cassava Sciences is 2.59 times more volatile than Axsome Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 7,486 in Axsome Therapeutics on August 30, 2024 and sell it today you would earn a total of 2,479 from holding Axsome Therapeutics or generate 33.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cassava Sciences vs. Axsome Therapeutics
Performance |
| Timeline |
| Cassava Sciences |
| Axsome Therapeutics |
Cassava Sciences and Axsome Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cassava Sciences and Axsome Therapeutics
The main advantage of trading using opposite Cassava Sciences and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cassava Sciences position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.| Cassava Sciences vs. Annovis Bio | Cassava Sciences vs. Axsome Therapeutics | Cassava Sciences vs. Reviva Pharmaceuticals Holdings | Cassava Sciences vs. Seres Therapeutics |
| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |